SAN FRANCISCO, Nov. 25, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that the U.S. Food ...
Kindred Biosciences (NASDAQ:KIN) +8.8% after-hours on news the Food and Drug Administration's Center for Veterinary Medicine approved Zimeta (dipyrone injection) for the control of pyrexia in horses.
SAN FRANCISCO, Nov. 16, 2015 /PRNewswire/ -- Kindred Biosciences, Inc. (KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced positive topline results ...
TMB and BRAF mutation status are independent predictive factors in stage IIIC/D/IV melanoma patients receiving adjuvant PD-1 antibodies. Overall survival in patients who received checkpoint inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback